SAFELY

Study Type:

Observational [Patient Registry]

Study Design:

Observational Model: Cohort

Time Perspective: Prospective

Estimated Enrollment: 600 participants

Target Follow-Up Duration: 10 Years

Official Title:

A Multi-center, Prospective Active Surveillance Registry Trial Assessing the Performance of a Non-invasive Immunogenomic Blood Test for Indolent Prostate Cancer Disease Management.